Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
151 publications have been identified in PubMed for neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan. Kisho has analyzed 89 by research type. Research spans Other (29%), Review / Meta-Analysis (18%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Other research | 26 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 8:14 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 16 | 18% |
Laboratory research | 15 | 17% |
Patient case studies | 14 | 16% |
Disease patterns and progression | 9 | 10% |
Testing and diagnosis research | 5 | 6% |
Clinical study results | 2 | 2% |
New treatment approaches | 2 | 2% |
Paroli M (2026). [PMID: 41432692](https://pubmed.ncbi.nlm.nih.gov/41432692/). *J Neurophysiol*. [Case Report / Case Series]
Torrey K (2026). [PMID: 42247610](https://pubmed.ncbi.nlm.nih.gov/42247610/). *J Neuromuscul Dis*. [Case Report / Case Series]
El-Dessouky SH (2026). [PMID: 41795876](https://pubmed.ncbi.nlm.nih.gov/41795876/). *Ophthalmic Genet*. [Basic Science / Preclinical]
Allergodt K (2026). [PMID: 40842110](https://pubmed.ncbi.nlm.nih.gov/40842110/). *Disabil Rehabil*. [Epidemiology / Natural History]
Demirkol H (2026). [PMID: 41124361](https://pubmed.ncbi.nlm.nih.gov/41124361/). *J Back Musculoskelet Rehabil*. [Case Report / Case Series]
Luo J (2026). [PMID: 41726576](https://pubmed.ncbi.nlm.nih.gov/41726576/). *Pediatr Investig*. [Clinical Trial Publication]
Fu Z (2026). [PMID: 41957353](https://pubmed.ncbi.nlm.nih.gov/41957353/). *Nat Commun*. [Gene Therapy / Novel Therapeutics]
Miller CL (2026). [PMID: 41486779](https://pubmed.ncbi.nlm.nih.gov/41486779/). *Ann Clin Transl Neurol*. [Basic Science / Preclinical]
Basu A (2026). [PMID: 40982308](https://pubmed.ncbi.nlm.nih.gov/40982308/). *J Child Neurol*. [Basic Science / Preclinical]
Schoser B (2026). [PMID: 41689635](https://pubmed.ncbi.nlm.nih.gov/41689635/). *J Neurol*. [Review / Meta-Analysis]